Anti-angiogenic/proliferative behavior of a "4-aryl-4H-chromene" on blood vessel's endothelial cells: A possible evidence on dual "anti-tumor" activity

Medicinal Chemistry Research

Volumn 20, Issue 7, 2011, Pages 920-929

  Mansouri, Kamran ^a   Khodarahmi, Reza ^a,b   Foroumadi, Alireza ^c   Mostafaie, Ali ^a   Motlagh, Hamidreza Mohammadi ^a  

^a KERMANSHAH UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b KERMANSHAH UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Anti angiogenesis; Anti proliferative; Chromene compounds; HUVEC; MMPs

Indexed keywords

2 AMINO 3 CYANO 7 (DIMETHYLAMINO) 4 (2 METHOXYPHENYL) 4H CHROMENE; 2 AMINO 3 CYANO 7 (DIMETHYLAMINO) 4 (3 NITROPHENYL) 4H CHROMENE; 2 AMINO 3 CYANO 7 (DIMETHYLAMINO) 4 (3 TRIFLUOROMETHYL PHENYL) 4H CHROMENE; CHROMENE DERIVATIVE; MATRIX METALLOPROTEINASE; UNCLASSIFIED DRUG;

ANTIANGIOGENIC ACTIVITY; ANTINEOPLASTIC ACTIVITY; ARTICLE; CELL MIGRATION; CELL PROLIFERATION; CHEMICAL STRUCTURE; HUMAN; HUMAN CELL; SYNTHESIS; UMBILICAL VEIN ENDOTHELIAL CELL;

EID: 80054739872     PISSN: 10542523     EISSN: 15548120     Source Type: Journal    
DOI: 10.1007/s00044-010-9418-y     Document Type: Article

References (37)

1. Arenberg DA, Strieter RM (1999) Angiogenesis. In: Serhan CN, Ward PA (eds) Molecular and cellular basis of inflammation. Humana Press, Totowa, pp 29-49
2. Bradford M (1976) A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248-254
3. Cai XS, Drewe J, Kemnitzer W (2009) Discovery of 4-aryl-4Hchromenes as potent apoptosis inducers using a cell-and caspase-based anti-cancer screening apoptosis program (ASAP): SAR studies and the identification of novel vascular disrupting agents. Anticancer Agents Med Chem 9:437-456
4. Chandrappa S, Chandru H, Sharada AC, Vinaya K, Ananda Kumar CS, Thimmegowda NR, Nagegowda P, Karuna Kumar M, Rangappa KS (2010) Synthesis and in vivo anticancer and antiangiogenic effects of novel thioxothiazolidin-4-one derivatives against transplantable mouse tumor. Med Chem Res 19:236-249
5. Decker T, Lohmann-Matthes ML (1988) A quick and simple method for the quantitation of lactate dehydrogenase release in measurements of cellular cytotoxicity and tumor necrosis factor (TNF) activity. J Immunol Methods 115:61-69
6. Deplanque G, Harris AL (2000) Anti-angiogenic agents: Clinical trial design and therapies in development. Eur J Cancer 36: 1713-1724 (Pubitemid 30616375)
7. Duncton MA, Piatnitski Chekler EL, Katoch-Rouse R, Sherman D, Wong WC, Smith LM II et al (2009) Arylphthalazines as potent, and orally bioavailable inhibitors of VEGFR-2. Bioorg Med Chem 17:731-740
8. Fife RS, Sledge GW Jr, Sissons S, Zerler B (2000) Effects of tetracyclines on angiogenesis in vitro. Cancer Lett 153:75-78 (Pubitemid 30209846)
9. Folkman J (2003) Angiogenesis and apoptosis. Semin Cancer Biol 13:159-167 (Pubitemid 36315933)
10. Foroumadi A, Dehghan G, Samzadeh-Kermani A, Arabsorkhi F, Sorkhi M, Shafiee A et al (2007a) Synthesis and antioxiodant activity of some novel 2-amino-4-aryl-3-cyano-7-(dimethylamino)-4H-chromenes. Asian J Chem 19:1391-1396
11. Foroumadi A, Samzadeh-Kermani A, Emami S, Dehghan G, Sorkhi M, Arabsorkhi F et al (2007b) Synthesis and antioxidant properties of substituted 3-benzylidene-7-alkoxychromsanon-4-ones. Bioorg Med Chem Lett 17:6764-6769 (Pubitemid 350061310)
12. Gangjee A, Namjoshi OA, Yu J, Ihnat MA, Thorpe JE, Warnke LA (2008) Design, synthesis and biological evaluation of substituted pyrrolo [2, 3-d] pyrimidines as multiple receptor tyrosine kinase inhibitors and antiangiogenic agents. Bioorg Med Chem 16:5514-5528 (Pubitemid 351694487)
13. Göoz P, Göoz M, Baldys A, Hoffman S (2009) ADAM-17 regulates endothelial cell morphology, proliferation, and in vitro angiogenesis. Biochem Biophys Res Commun 380:33-38
14. Gorman A, McCarthy J, Finucane D, Reville W, Gotter T (1996) Morphological assessment of apoptosis. In: Gotter TG, Martin ST (eds) Techniques in apoptosis. A user's guide. Portland Press Ltd, London, pp 6-7
15. Hanahan D, Folkman J (1996) Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell 86:353-364 (Pubitemid 26272076)
16. Hanahan D, Weinberg RA (2000) The hallmarks of cancer. Cell 100:57-70 (Pubitemid 30046295)
17. Hata-Sugi N, Kawase-Kageyama R, Wakabayashi T (2002) Characterization of rat aortic fragment within collagen gel as an angiogenesis model; capillary morphology may reflect the action mechanisms of angiogenesis inhibitors. Biol Pharm Bull 25:446-451 (Pubitemid 40036733)
18. Kappert K, Meyborg H, Baumann B, Furundzija V, Kaufmann J, Graf K et al (2009) Integrin cleavage facilitates cell surface-associated proteolysis required for vascular smooth muscle cell invasion. Int J Biochem Cell Biol 41:1511-1517
19. Karp G (2002) Cellular and molecular biology, concepts and experiments. Wiley, New York, pp 671-702
20. Kasibhatla S, Gourdeau H, Meerovitch K, Drewe J, Reddy S, Qiu L, Zhang H, Bergeron F, Bouffard D, Yang Q, Herich J, Lamothe S, Xiong Cai S, Tseng B (2004) Discovery and mechanism of action of a novel series of apoptosis inducers with potential vascular targeting activity. Mol Cancer Ther 3:1365-1373 (Pubitemid 39562581)
21. Kemnitzer W, Drewe J, Jiang S, Zhang H, Wang Y, Zhao J et al (2004) Discovery of 4-aryl-4H-chromenes as a new series of apoptosis inducers using a cell-and caspase-based highthroughput screening assay. 1. Structure-activity relationships of the 4-aryl group. J Med Chem 47:6299-6310 (Pubitemid 39587254)
22. Kemnitzer W, Kasibhatla S, Jiang S, Zhang H, Wang Y, Zhao J et al (2005) 4-Aryl-4H-chromenes as a new series of apoptosis inducers using a cell-and caspase-based high throughput screening assay, structure-activity relationships of the 7,8-positions. Bioorg Med Chem Lett 15:4745-4751 (Pubitemid 41354799)
23. Kemnitzer W, Drewe J, Jiang S, Zhang H, Wang Y, Zhao J et al (2007) Discovery of 4-aryl-4H-chromenes as a new series of apoptosis inducers using a cell-and caspase-based highthroughput screening assay. 3. Structure-activity relationships of fused rings at the 7, 8-positions. J Med Chem 50:2858-2864 (Pubitemid 46980856)
24. Keshavarz M, Mostafaie A, Mansouri K, Shakiba Y, Mohamadi Motlagh HR (2009) Inhibition of corneal neovascularization with propolis extract. Arch Med Res 40:59-61
25. Keshavarz M, Mostafaie A, Mansouri K, Bidmeshkipour A, Mohammadi Motlagh HR, Parvaneh S (2010) In vitro and ex vivo antiangiogenic activity of Salvia officinalis. Phytother Res (in press).
26. Kuwano M, Fukushi J, Okamoto M, Nishie A, Goto H, Ishibashi T et al (2001) Angiogenesis factors. Intern Med 40:565-572 (Pubitemid 32799384)
27. Mostafaie A, Bidmeshkipour A, Shirvani Z, Mansouri K, Chalabi M (2008) A proper new collagenase for isolation of cells from different tissues. Appl Biochem Biotechnol 144:123-131
28. Nakao Y, Narazaki G, Hoshino T, Maeda S, Yoshida M, Maejima H et al (2008) Evaluating of antiangiogenic activity of azumamides by the in vitro vascular organization model using mouse induced pluripotent stem (iPS) cells. Bioorg Med Chem Lett 18: 2982-2984 (Pubitemid 351608862)
29. Plank MJ, Sleeman BDJ (2003) Tumour-induced angiogenesis: A review. J Theor Med 5:137-153 (Pubitemid 40011956)
30. Ribatti D, Vacca A, Dammacco F (1999) The role of the vascular phase in solid tumor growth: A historical review. Neoplasia 4:293-302
31. Shepherd FA (2001) Angiogenesis inhibitors in the treatment of lung cancer. Lung Cancer 34:S81-S89
32. Singh RK, Gutman M, Bucana CD, Sanchez R, Llansa N, Fidler IJ (1995) Interferons alpha and beta down-regulate the expression of basic fibroblast growth factor in human carcinomas. Proc Natl Acad Sci USA 92:4562-4568
33. Toth M, Fridman R (2001) Assessment of gelatinases (MMP-2 and MMP-9) by gelatin zymography. Methods Mol Med 57:163-174
34. Verma RP, Hansch C (2007) Matrix metalloproteinases (MMPs): Chemical-biological functions and (Q) SARs. Bioorg Med Chem 15:2223-2268 (Pubitemid 46240907)
35. Volpert OV, Dameron KM, Bouck N (1998) A human fibrosarcoma inhibits systemic angiogenesis and the growth of experimental metastases via thrombospondin-1. Oncogene 14:1495-1498
36. Yamashita T, Nakao Y, Matsunaga S, Oikawa T, Imahara Y, Fusetani N (2009) A new antiangiogenic C24 oxylipin from the soft coral Sinularia numerosa. Bioorg Med Chem 17:2181-2184
37. Zhang S, Zhang D, Sun B (2007) Vasculogenic mimicry: Current status and future prospects. Cancer Lett 254:157-164 (Pubitemid 47126687)